Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease
Clinical trial NCT01196871 · COMPLETED
Trial details
- NCT number
- NCT01196871
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-02
- Primary completion
- 2012-10-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.